KRATZ FELIX has a total of 18 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are D&D PHARMATECH INC, PROLONG PHARMACEUTICALS INC and STEALTH PEPTIDES INTERNAT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Sugars | |
#6 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Kratz Felix | 18 |
#2 | Hochdoerffer Katrin | 2 |
#3 | Warnecke Andre | 2 |
#4 | Elsadek Bakheet | 1 |
#5 | Schmid Bjoern | 1 |
#6 | Merfort Irmgard | 1 |
Publication | Filing date | Title |
---|---|---|
AU4548997A | Antineoplastic conjugates of transferrin, albumin and polyethylene glycol |